Abstract
Selective prostatic arterial infusion yielded higher radiotracer uptake in prostatic tumors than intravenous infusions when using dynamic prostate-specific membrane antigen PET/CT to simulate radioligand therapy.

This publication has 15 references indexed in Scilit: